Home LiteratureArticle Details
PMID: 7837392 Published · ppublish English Journal Article

Assessment and counseling for women with a family history of breast cancer. A guide for clinicians.

JAMA ·Vol. 273 ·No. 7 ·1995-02-15 ·Pages 577-85

Hoskins KF, Stopfer JE, Calzone KA, Merajver SD, Rebbeck TR, Garber JE, Weber BL

Abstract

More women in all risk categories are seeking information regarding their individual breast cancer risk, and there is a need for their primary care clinicians to be able to assess familial risk factors for breast cancer, provide individualized risk information, and offer surveillance recommendations. Estimates of the number of women with a family history of breast cancer range from approximately 5% to 20%, depending on the population surveyed. Many of these women will not have a family history that suggests the presence of a highly penetrant breast cancer susceptibility gene. However, a small subset of such women will come from families with a striking incidence of breast and other cancers often associated with inherited mutations. The development and refinement of risk prediction models provide an epidemiologic basis for counseling women with a family history that does not appear related to a dominant susceptibility gene. contrast, the recent isolation of BRCA1, the localization of BRCA2, and the acknowledgement that additional breast cancer susceptibility genes must exist provide a molecular basis for counseling some high-risk women. We present a guide for primary care clinicians that may be helpful in defining families as moderate or high risk, in determining individual risk in women with a family history of breast cancer based on this distinction, and for counseling women in a setting where the data necessary to design surveillance and prevention strategies are lacking. We include criteria for selecting women who may be candidates for detection of inherited mutations in breast cancer susceptibility genes.

Related Genes
MeSH Terms
BRCA1 Protein Breast Neoplasms/epidemiology,genetics,prevention & control Causality Counseling/standards DNA/analysis Female Genetic Testing Humans Mutation Neoplasm Proteins/genetics Pedigree Practice Guidelines as Topic Risk Assessment Transcription Factors/genetics United States
Chemicals
BRCA1 Protein Neoplasm Proteins Transcription Factors DNA
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Hoskins K F
Department of Internal Medicine, University of Pennsylvania, Philadelphia.
Stopfer J E
Calzone K A
Merajver S D
Rebbeck T R
Garber J E
Weber B L
Article Info
Journal
JAMA
Abbr.
JAMA
ISSN
0098-7484
Published
1995-02-15
Pages
577-85
Language
English
Region
United States
NLM ID
7501160
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com